The Antitumor Effects of Interferon

Overview

Journal Med Oncol Tumor Pharmacother

Specialties Oncology
Pharmacology

Date 1986 Jan 1

PMID 2433551

Citations 1

Authors

I GRESSER

Affiliations

Soon will be listed here.

Abstract

Interferons show antitumor activity in patients with various malignancies. The mechanism(s) of the antitumor effects are not altogether clear. In one experimental animal model discussed herein, mice were injected with Friend erythroleukemia cells and treated with mouse interferon alpha/beta. The results suggest that interferon does not act directly on the tumor cells but acts via host mechanisms that are still ill defined.

Citing Articles

JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression.

Owen K, Brockwell N, Parker B Cancers (Basel). 2019; 11(12).

PMID: 31842362 PMC: 6966445. DOI: 10.3390/cancers11122002.

References

Gall S, Hughes C, Trofatter K . Interferon for the therapy of condyloma acuminatum. Am J Obstet Gynecol. 1985; 153(2):157-63. DOI: 10.1016/0002-9378(85)90103-6. View

Borden E, HOLLAND J, Dao T, Gutterman J, Wiener L, Chang Y . Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial. Ann Intern Med. 1982; 97(1):1-6. DOI: 10.7326/0003-4819-97-1-1. View

NILSONNE U, Strander H . [The results of a combination of interferon and selective surgery in the treatment of osteosarcoma (author's transl)]. Rev Chir Orthop Reparatrice Appar Mot. 1981; 67(3):193-7. View

Merigan T, Sikora K, Breeden J, Levy R, Rosenberg S . Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. N Engl J Med. 1978; 299(26):1449-53. DOI: 10.1056/NEJM197812282992608. View

GRESSER I, Bandu M, Tovey M, Bodo G, Paucker K, Stewart 2nd W . Interferon and cell division. VII. Inhibitory effect of highly purified interferon preparations on the multiplication of leukemia L 1210 cells. Proc Soc Exp Biol Med. 1973; 142(1):7-10. DOI: 10.3181/00379727-142-36945. View

Foon K, Sherwin S, Abrams P, Longo D, Fer M, Stevenson H . Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon. N Engl J Med. 1984; 311(18):1148-52. DOI: 10.1056/NEJM198411013111803. View

McCabe B, Clark K . Interferon and laryngeal papillomatosis. The Iowa experience. Ann Otol Rhinol Laryngol. 1983; 92(1 Pt 1):2-7. DOI: 10.1177/000348948309200102. View

Freedman R, Gutterman J, Wharton J, RUTLEDGE F . Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinoma. J Biol Response Mod. 1983; 2(2):133-8. View

Retsas S, Priestman T, Newton K, Westbury G . Evaluation of human lymphoblastoid interferon in advanced malignant melanoma. Cancer. 1983; 51(2):273-6. DOI: 10.1002/1097-0142(19830115)51:2<273::aid-cncr2820510218>3.0.co;2-k. View

10.

Sawada T, Takamatsu T, Tanaka T, Mino M, Fujita K, Kusunoki T . Effects of intralesional interferon on neuroblastoma: changes in histology and DNA content distribution of tumor masses. Cancer. 1981; 48(10):2143-6. DOI: 10.1002/1097-0142(19811115)48:10<2143::aid-cncr2820481004>3.0.co;2-6. View

11.

Quesada J, Rios A, Swanson D, Trown P, Gutterman J . Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J Clin Oncol. 1985; 3(11):1522-8. DOI: 10.1200/JCO.1985.3.11.1522. View

12.

Hersey P, Hasic E, MacDonald M, Edwards A, Spurling A, Coates A . Effects of recombinant leukocyte interferon (rIFN-alpha A) on tumour growth and immune responses in patients with metastatic melanoma. Br J Cancer. 1985; 51(6):815-26. PMC: 1977086. DOI: 10.1038/bjc.1985.127. View

13.

GRESSER I . The antitumor effect of interferon in lymphocyte- and macrophage-depressed mice. Proc Soc Exp Biol Med. 1973; 144(3):896-900. DOI: 10.3181/00379727-144-37706. View

14.

Oberg K, Alm G, Lindstrom H, Lundqvist G . Successful treatment of therapy-resistant pancreatic cholera with human leucocyte interferon. Lancet. 1985; 1(8431):725-7. DOI: 10.1016/s0140-6736(85)91265-6. View

15.

Ahre A, Bjorkholm M, Mellstedt H, Brenning G, ENGSTEDT L, Gahrton G . Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden. Cancer Treat Rep. 1984; 68(11):1331-8. View

16.

Borden E, Balkwill F . Preclinical and clinical studies of interferons and interferon inducers in breast cancer. Cancer. 1984; 53(3 Suppl):783-9. DOI: 10.1002/1097-0142(19840201)53:3+<783::aid-cncr2820531329>3.0.co;2-i. View

17.

GRESSER I . How does interferon inhibit tumour growth?. Philos Trans R Soc Lond B Biol Sci. 1982; 299(1094):69-76. DOI: 10.1098/rstb.1982.0107. View

18.

Fellous M, Bono R, Hyafil F, GRESSER I . Interferon enhances the amount of membrane-bound beta2-microglobulin and its release from human Burkitt cells. Eur J Immunol. 1981; 11(6):524-6. DOI: 10.1002/eji.1830110616. View

19.

Lindahl P, Leary P, GRESSER I . Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells. Proc Natl Acad Sci U S A. 1973; 70(10):2785-8. PMC: 427109. DOI: 10.1073/pnas.70.10.2785. View

20.

GRESSER I . Inhibition by interferon preparations of a solid malignant tumour and pulmonary metastasis in mice. Nat New Biol. 1972; 236(64):78-9. DOI: 10.1038/newbio236078a0. View